SARAH BLANKENHEIMER: Open Payments
NPI 1265940415 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,243 in 320 payments from 21 companies in 2025. Trend: 2023 $340 · 2024 $4,615 · 2025 $5,243
Food & beverage: $5,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 92 | $1,286 |
| Amgen Inc. | 64 | $1,125 |
| Janssen Biotech, Inc. | 29 | $474 |
| UCB, Inc. | 25 | $449 |
| AstraZeneca Pharmaceuticals LP | 17 | $325 |
| PFIZER INC. | 16 | $313 |
| Novartis Pharmaceuticals Corporation | 29 | $267 |
| Mallinckrodt Hospital Products Inc. | 9 | $204 |
| Radius Health, Inc. | 9 | $164 |
| GENZYME CORPORATION | 5 | $110 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Bimzelx, XELJANZ, COSENTYX, UPLIZNA, KRYSTEXXA.
Industry payments across AZ — which companies pay providers there.
